Just a reminder to the CEO to ensure he does not fall foul of false claims. Reimbursement in the US goes to the Doctor for monitoring the patient, capturing data points in a 30 day period and using that data to interact with the pateint and make clinical decisions. Reimbursement is not to ADR and its not for the product. If ADR can tap into that and get the license fees etc. they could be off an running. This is all CMS Medicare - they need to, report on claims and payments made, establish confidence with no clawbacks and get the private insurers on board to scale the opportunity.
media, page-2
Add ADR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.102M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 756844 | 1.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.5¢ | 100000 | 1 |
View Market Depth
| Last trade - 16.12pm 02/10/2024 (20 minute delay) ? |
| ADR (ASX) Chart |
Day chart unavailable